Raksha Shah

Ms. Raksha Shah has 30 years of leadership experience in large pharma companies like Novartis and GlaxoSmithKline (GSK) and technology and life science start-up companies. She currently serves on the Joint Steering Committee of Poseidon Ventures ($65M Deerfield Management – UCSD Venture); and as a mentor to early stage companies in her capacity as the chancellor-appointed, life science Entrepreneur in Residence at UCSD. She was most recently the Founder, Chief Executive Officer, and Board Chair of Obsidio Therapeutics, a first in class small molecule Oncology Company. Prior to Obsidio, she was a founder of two tech start-ups, the first, a documentation software company where she served as Chief Financial Officer and the second an audit automation software company, Reliant Solutions where she served as Chief Operating Officer and Board Director. Upon moving to southern California from the UK in 1988, she joined Ciba-Geigy/Novartis in sales and sales management positions. In the UK, as a marketing leader for GSK, she developed the strategic plans and executed the successful global launch and commercialization of two of GSK’s drugs. She received her BSc. in Biology and her MBA in Finance & Marketing in the UK.